Nuo Therapeutics: Nuo Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024

Nuo Therapeutics, Inc. reported earnings results for the full year ended December 31, 2024. For the full year, the company reported revenue was USD 1.37 million compared to USD 0.608525 million a year ago. Net loss was USD 2.32 million compared to USD 3.17 million a year ago. Basic loss per share from continuing operations was USD 0.05 compared to USD 0.08 a year ago. Diluted loss per share from continuing operations was USD 0.05 compared to USD 0.08 a year ago. Nuo Therapeutics, Inc. reported earnings results for the full year ended December 31, 2024. For the full year, the company reported revenue was USD 1.37 million compared to USD 0.608525 million a year ago. Net loss was USD 2.32 million compared to USD 3.17 million a year ago. Basic loss per share from continuing operations was USD 0.05 compared to USD 0.08 a year ago. Diluted loss per share from continuing operations was USD 0.05 compared to USD 0.08 a year ago.